Dr. Raheel Iftikhar weighs in on AI in blood cancers
Dr. Iftikhar is the SOHO Ambassador to Pakistan and a consultant clinical hematologist and hematopoietic stem cell transplantation physician at Armed Forces Bone
SOHO 2025
Ambassador Program
Lymphoma
Aggressive B-Cell Lymphomas
Multiple Myeloma
News
AACR 2026
Cellular Therapy
Multiple Myeloma
News
In vivo CAR-T shows promise but safety is a concern
In vivo CAR-T therapy, which eliminates the complex manufacturing required for current ex vivo approaches, could represent the next generation of treatment, but
Community Oncology News
Trending now
Lymphoma
Aggressive B-Cell Lymphomas
Indolent B-Cell Lymphomas
Mantle Cell Lymphoma
T-Cell Lymphoma
Video Interviews
Watch: Dr. Krish Patel on building partnerships between community and academic centers
In this session from the SOHO Insider Community Oncology Brown Bag series, Dr. Krish Patel provides an overview on building partnerships between community
AACR 2026
Cellular Therapy
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Aggressive B-Cell Lymphomas
Meetings / Conferences
Multiple Myeloma
Myelodysplastic Syndromes
News
NCI director says institute is ‘stable’ after turbulent year
During a session at AACR 2026, NCI Director Anthony Letai, MD, PhD, said that despite a turbulent past year, the institute is stable
News
SOHO Israel postponed until November 19–20
We would like to inform you of an important update regarding the 4th SOHO-Israel Meeting & 10th International Davidoff Conference. In light of
AACR 2026
Cellular Therapy
Leukemia
Lymphoma
Meetings / Conferences
Multiple Myeloma
Myelodysplastic Syndromes
News
Former FDA-OCE Director Richard Pazdur: ‘there is a palpable sense of anxiety at FDA’
At the AACR-Oncology Partnering event, Richard Pazdur, former FDA-OCE director discusses FDA morale, politics and AI shift.
AACR 2026
Cellular Therapy
Leukemia
Lymphoma
Meetings / Conferences
News
Clinical care still needs human intelligence in the AI era
Human intelligence will be more important than ever as artificial intelligence continues to proliferate throughout clinical care, according Yu Shyr, PhD, FAACR, chair
Trending now
Multiple Myeloma
OPN-6602 in MM granted FDA Fast Track Designation
The US Food and Drug Administration (FDA) has granted Fast Track Designation to OPN-6602, an oral small-molecule EP300/CBP inhibitor, for patients with relapsed
AACR 2026
Acute Lymphoblastic Leukemia
Multiple Myeloma
SOHO President Dr. John F. DiPersio honored with top AACR award
The award recognizes an individual's achievements and contributions in any aspect of blood cancer research.
SOHO 2026
Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndromes
News
Society Updates
SOHO announces exclusive MDS, AML session on September 8 in Houston; register now
SOHO will hold an exclusive session titled, “Practical Strategies for Optimizing Outcomes in MDS and AML,” starting at 3 pm on Tuesday, September